2.085
Acurx Pharmaceuticals Inc Borsa (ACXP) Ultime notizie
1.65M ACXP warrant shares registered for resale by Acurx (NASDAQ: ACXP) - Stock Titan
Acurx (NASDAQ: ACXP) files S-1 to register 1.3M Lincoln Park resale shares - Stock Titan
Mouse study links Acurx antibiotics to MRSA drop, gut microbes preserved - Stock Titan
Can Acurx Pharmaceuticals (ACXP) climb 226.3% to reach the level Wall Street analysts expect? - MSN
ACXP Stock Price, Quote & Chart | ACURX PHARMACEUTICALS INC (NASDAQ:ACXP) - ChartMill
Replay to follow Acurx CEO's virtual A.G.P. healthcare fireside chat - Stock Titan
Is Acurx Pharmaceuticals (ACXP) stock outpacing its medical peers this year? - MSN
Acurx Pharmaceuticals, Inc. To Present at The Market Movers Investor Summit - The Globe and Mail
Acurx Pharmaceuticals announces up to $7.1M offering - MSN
ACXP Forecast, Price Target & Analyst Ratings | ACURX PHARMACEUTICALS INC (NASDAQ:ACXP) - ChartMill
ACXP (Acurx Pharmaceuticals Inc.) posts far stronger Q4 2025 EPS than analyst estimates, but shares fall 4.42 percent today.Consensus Beat - UBND thành phố Hải Phòng
Acurx (ACXP) director Carl Sailer awarded 2,150 stock options at $2.36 - Stock Titan
Acurx (NASDAQ: ACXP) director gets 2,150 stock options grant - Stock Titan
Acurx Pharmaceuticals (ACXP) director awarded 2,150 stock options as board pay - Stock Titan
Acurx Pharmaceuticals (ACXP) director awarded 2,150 stock options at $2.36 strike - Stock Titan
Acurx Pharmaceuticals (ACXP) director receives 2,150 stock options grant - Stock Titan
Acurx Pharmaceuticals (ACXP) director awarded 37,100 stock options at $2.36 - Stock Titan
Acurx Pharmaceuticals (ACXP) CEO awarded 37,100 stock options at $2.36 - Stock Titan
CFO of Acurx (NASDAQ: ACXP) receives 25,900 stock options award - Stock Titan
Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update - Weekly Voice
Biopharmaceutical company Acurx Pharmaceuticals announced plans to hold an investor conference call on May 12, 2026, during which it will provide a detailed overview of its financial results for the first quarter of 2026. - Bitget
Acurx Pharmaceuticals to discuss first quarter 2026 financial results on May 12, 2026 conference call and provide business update - marketscreener.com
Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update - TradingView
Acurx will discuss Q1 results and a business update on May 12 - Stock Titan
Acurx Pharmaceuticals | CORRESP: CORRESP - Moomoo
Acurx Pharmaceuticals closes $2.5M financing with warrants By Investing.com - Investing.com Australia
Crude Oil Gains Over 2%; PepsiCo Posts Upbeat Q1 Earnings - Sahm
Dow Surges Over 100 Points; US Initial Jobless Claims Fall - Sahm
Acurx Pharmaceuticals, Inc. announces closing of up to $7.1 million registered direct offering priced at-the-market under Nasdaq rules - marketscreener.com
Acurx Pharmaceuticals closes $2.5M financing with warrants - Investing.com
Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - ChartMill
Acurx Pharmaceuticals raises $2.5M in direct offering By Investing.com - Investing.com South Africa
Acurx Pharmaceuticals, Inc. Announces up to $ - Moomoo
Acurx Pharmaceuticals Secures New Financing to Advance Pipeline - TipRanks
Acurx Pharmaceuticals (NASDAQ: ACXP) sells 816,068 shares; raises ~$2.2M - Stock Titan
Acurx Pharmaceuticals raises $2.5M in direct offering - Investing.com
Acurx Pharmaceuticals | 424B5: Prospectus - Moomoo
Acurx Pharmaceuticals (ACXP) raises $2.5M with warrants for up to $4.6M more - Stock Titan
Acurx lines up $2.5M now, another $4.6M if warrants are used - Stock Titan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Sahm
Market Leaders: What analysts say about Acurx Pharmaceuticals Inc stock2026 Outlook & Daily Profit Focused Stock Screening - baoquankhu1.vn
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX) - Scott Coop
New to The Street Broadcasts on Bloomberg TV, Featuring IGC, VVOS, ACXP, and EQX - National Today
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):